{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:52:06Z","timestamp":1788389526984,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62476285"],"award-info":[{"award-number":["62476285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01591-5","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:25:13Z","timestamp":1741847113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predicting sentinel lymph node metastasis in breast cancer: a study based on the SEER database"],"prefix":"10.1007","volume":"25","author":[{"given":"Qingyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"3","key":"1591_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1591_CR2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370.","journal-title":"J Clin Oncol"},{"key":"1591_CR3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the Almanac trial. J Natl Cancer Inst. 2006;98:599\u2013609.","journal-title":"J Natl Cancer Inst"},{"key":"1591_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391\u20138.","journal-title":"Ann Surg"},{"key":"1591_CR5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","volume":"2","author":"DN Krag","year":"1993","unstructured":"Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335\u20139.","journal-title":"Surg Oncol"},{"issue":"5","key":"1591_CR6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561\u20134.","journal-title":"J Clin Oncol"},{"key":"1591_CR7","unstructured":"National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology: breast, version 2. (2008)."},{"key":"1591_CR8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.soc.2005.04.005","volume":"14","author":"S Natarajan","year":"2005","unstructured":"Natarajan S, Taneja C, Cady B. Evolution of lymphadenectomy in surgical oncology. Surg Oncol Clin N Am. 2005;14:447\u201359.","journal-title":"Surg Oncol Clin N Am"},{"key":"1591_CR9","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011. J Clin Oncol. 2007;25:3657\u201363.","journal-title":"J Clin Oncol"},{"key":"1591_CR10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546\u201353.","journal-title":"N Engl J Med"},{"issue":"4","key":"1591_CR11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(20010815)92:4<748::AID-CNCR1378>3.0.CO;2-V","volume":"92","author":"SF Sener","year":"2001","unstructured":"Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92(4):748\u201352.","journal-title":"Cancer"},{"issue":"4","key":"1591_CR12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/cncr.11545","volume":"98","author":"JS Rietman","year":"2003","unstructured":"Rietman JS, Dijkstra PU, Geertzen JH, et al. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast carcinoma. Cancer. 2003;98(4):690\u20136.","journal-title":"Cancer"},{"issue":"11","key":"1591_CR13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","volume":"157","author":"JM Simons","year":"2022","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, et al. Diagnostic accuracy of radioactive iodine seed Placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. JAMA Surg. 2022;157(11):991\u20139.","journal-title":"JAMA Surg"},{"issue":"10","key":"1591_CR14","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1591_CR15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378\u201382.","journal-title":"Ann Surg"},{"key":"1591_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2023.06.011","volume":"71","author":"AKE van Hemert","year":"2023","unstructured":"van Hemert AKE, van Duijnhoven FH, Vrancken Peeters MTFD. This house believes that: MARI\/TAD is better than sentinel node biopsy after PST for cN+ patients. Breast. 2023;71:89\u201395.","journal-title":"Breast"},{"issue":"18","key":"1591_CR17","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2217\/fon-2021-1647","volume":"18","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Cusmai A, Acquafredda S, et al. KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer. Future Oncol. 2022;18(18):2301\u20139.","journal-title":"Future Oncol"},{"issue":"12","key":"1591_CR18","first-page":"624","volume":"31","author":"DC Guven","year":"2023","unstructured":"Guven DC, Erul E, Kaygusuz Y, et al. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data. Support Care Cancer. 2023;31(12):624.","journal-title":"Support Care Cancer"},{"issue":"14","key":"1591_CR19","doi-asserted-by":"crossref","first-page":"1362641","DOI":"10.3389\/fonc.2024.1362641","volume":"26","author":"R Caputo","year":"2024","unstructured":"Caputo R, Buono G, Piezzo M, et al. Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis. Front Oncol. 2024;26(14):1362641.","journal-title":"Front Oncol"},{"issue":"6","key":"1591_CR20","doi-asserted-by":"crossref","first-page":"102198","DOI":"10.1016\/j.esmoop.2023.102198","volume":"8","author":"A Rizzo","year":"2023","unstructured":"Rizzo A, Schipilliti FM, Di Costanzo F, et al. Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis. ESMO Open. 2023;8(6):102198.","journal-title":"ESMO Open"},{"issue":"5","key":"1591_CR21","first-page":"352","volume":"13","author":"E Vitale","year":"2024","unstructured":"Vitale E, Rizzo A, Santa K, et al. Associations between \u201ccancer risk\u201d, \u201cinflammation\u201d and \u201cmetabolic syndrome\u201d: a scoping review. Biology (Basel). 2024;13(5):352.","journal-title":"Biology (Basel)"},{"issue":"5","key":"1591_CR22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","volume":"21","author":"O Gentilini","year":"2012","unstructured":"Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European institute of oncology of Milan (SOUND: sentinel node vs observation after axillary UltraSouND). Breast. 2012;21(5):678\u201381.","journal-title":"Breast"},{"issue":"Suppl 1","key":"1591_CR23","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.breast.2021.11.018","volume":"62","author":"EH Hersh","year":"2022","unstructured":"Hersh EH, King TA. De-escalating axillary surgery in early-stage breast cancer. Breast. 2022;62(Suppl 1):S43\u20139.","journal-title":"Breast"},{"issue":"1","key":"1591_CR24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","volume":"17","author":"LM Van Roozendaal","year":"2017","unstructured":"Van Roozendaal LM, Vane MLG, van Dalen T, et al. Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013\u201308). BMC Cancer. 2017;17(1):459.","journal-title":"BMC Cancer"},{"issue":"18","key":"1591_CR25","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","volume":"27","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009;27(18):2946\u201353.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1591_CR26","doi-asserted-by":"crossref","first-page":"89778","DOI":"10.1371\/journal.pone.0089778","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Mittendorf EA, Sahin AA, et al. Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS ONE. 2014;9(2):89778.","journal-title":"PLoS ONE"},{"key":"1591_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.breast.2022.02.014","volume":"63","author":"Z Gou","year":"2022","unstructured":"Gou Z, Lu X, He M, et al. Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis. Breast. 2022;63:9\u201315.","journal-title":"Breast"},{"issue":"3","key":"1591_CR28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10549-022-06746-6","volume":"196","author":"Q Zheng","year":"2022","unstructured":"Zheng Q, Luo H, Xia W, et al. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study. Breast Cancer Res Treat. 2022;196(3):613\u201322.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1591_CR29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2020.03.284","volume":"31","author":"S Paluch-Shimon","year":"2020","unstructured":"Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO 4th international consensus guidelines for breast cancer in young women (BCY4). Ann Oncol. 2020;31(6):674\u201396.","journal-title":"Ann Oncol"},{"issue":"18","key":"1591_CR30","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1016\/j.ejca.2012.10.004","volume":"48","author":"F Cardoso","year":"2012","unstructured":"Cardoso F, Loibl S, Pagani O, et al. The European society of breast cancer specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48(18):3355\u201377.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1591_CR31","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1186\/s12885-018-4982-5","volume":"18","author":"FG Ye","year":"2018","unstructured":"Ye FG, Xia C, Ma D, et al. Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study. BMC Cancer. 2018;18(1):1085.","journal-title":"BMC Cancer"},{"issue":"4","key":"1591_CR32","doi-asserted-by":"crossref","first-page":"e0301057","DOI":"10.1371\/journal.pone.0301057","volume":"19","author":"K Zhu","year":"2024","unstructured":"Zhu K, Sui Y, Zhu M, et al. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: a SEER population-based study. PLoS ONE. 2024;19(4):e0301057.","journal-title":"PLoS ONE"},{"issue":"1","key":"1591_CR33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12885-021-08313-6","volume":"21","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang B, Liu N, et al. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study. BMC Cancer. 2021;21(1):565.","journal-title":"BMC Cancer"},{"key":"1591_CR34","doi-asserted-by":"crossref","first-page":"608334","DOI":"10.3389\/fonc.2020.608334","volume":"10","author":"X Cui","year":"2020","unstructured":"Cui X, Zhu H, Huang J. Nomogram for predicting lymph node involvement in triple-negative breast cancer. Front Oncol. 2020;10:608334.","journal-title":"Front Oncol"},{"issue":"11","key":"1591_CR35","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.7150\/jca.30386","volume":"10","author":"YX Zhao","year":"2019","unstructured":"Zhao YX, Liu YR, Xie S, et al. A nomogram predicting lymph node metastasis in T1 breast cancer based on the surveillance, epidemiology, and end results program. J Cancer. 2019;10(11):2443\u20139.","journal-title":"J Cancer"},{"key":"1591_CR36","first-page":"3866907","volume":"2021","author":"Y Min","year":"2021","unstructured":"Min Y, Wei X, Chen H, et al. Identifying clinicopathological risk factors of the regional lymph node metastasis in patients with T1\u20132 mucinous breast cancer: a population-based study. J Oncol. 2021;2021:3866907.","journal-title":"J Oncol"},{"key":"1591_CR37","doi-asserted-by":"crossref","first-page":"967062","DOI":"10.3389\/fendo.2022.967062","volume":"13","author":"X Gao","year":"2022","unstructured":"Gao X, Luo W, He L, et al. Nomogram models for stratified prediction of axillary lymph node metastasis in breast cancer patients (cN0). Front Endocrinol (Lausanne). 2022;13:967062.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"24","key":"1591_CR38","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1002\/cam4.4804","volume":"11","author":"SL Wu","year":"2022","unstructured":"Wu SL, Gai JD, Yu XM, et al. A novel nomogram and risk classification system for predicting lymph node metastasis of breast mucinous carcinoma: a SEER-based study. Cancer Med. 2022;11(24):4767\u201383.","journal-title":"Cancer Med"},{"issue":"7","key":"1591_CR39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/1055-9965.1128.13.7","volume":"13","author":"WF Anderson","year":"2004","unstructured":"Anderson WF, Chu KC, Chang S, et al. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13(7):1128\u201335.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"24","key":"1591_CR40","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1002\/cncr.29687","volume":"121","author":"SM Wong","year":"2015","unstructured":"Wong SM, Freedman RA, Sagara Y, et al. The effect of paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma. Cancer. 2015;121(24):4333\u201340.","journal-title":"Cancer"},{"key":"1591_CR41","doi-asserted-by":"crossref","first-page":"981059","DOI":"10.3389\/fonc.2022.981059","volume":"12","author":"C Jiang","year":"2022","unstructured":"Jiang C, Xiu Y, Qiao K, et al. Prediction of lymph node metastasis in patients with breast invasive micropapillary carcinoma based on machine learning and SHapley additive explanations framework. Front Oncol. 2022;12:981059.","journal-title":"Front Oncol"},{"issue":"2","key":"1591_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2014.17322","volume":"313","author":"J Iqbal","year":"2015","unstructured":"Iqbal J, Ginsburg O, Rochon PA, et al. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165\u201373.","journal-title":"JAMA"},{"key":"1591_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1072-7515(00)00310-0","volume":"191","author":"DE Rivadeneira","year":"2000","unstructured":"Rivadeneira DE, Simmons RM, Christos PJ, et al. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg. 2000;191:1\u20136.","journal-title":"J Am Coll Surg"},{"key":"1591_CR44","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/CMAR.S165291","volume":"10","author":"ZC Gou","year":"2018","unstructured":"Gou ZC, Liu XY, Xiao Y, et al. Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study. Cancer Manag Res. 2018;10:1133\u201341.","journal-title":"Cancer Manag Res"},{"key":"1591_CR45","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1016\/j.clbc.2018.05.007","volume":"18","author":"C Siotos","year":"2018","unstructured":"Siotos C, McColl M, Psoter K, et al. Tumor site and breast cancer prognosis. Clin Breast Cancer. 2018;18:e1045\u201352.","journal-title":"Clin Breast Cancer"},{"key":"1591_CR46","doi-asserted-by":"crossref","first-page":"e20297","DOI":"10.1371\/journal.pone.0020297","volume":"6","author":"F Reyal","year":"2011","unstructured":"Reyal F, Rouzier R, Depont-Hazelzet B, et al. The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma. PLoS ONE. 2011;6:e20297.","journal-title":"PLoS ONE"},{"issue":"2","key":"1591_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4048\/jbc.2015.18.2.143","volume":"18","author":"MD Mattes","year":"2015","unstructured":"Mattes MD, Bhatia JK, Metzger D, et al. Breast Cancer subtype as a predictor of lymph node metastasis according to the SEER registry. J Breast Cancer. 2015;18(2):143\u20138.","journal-title":"J Breast Cancer"},{"issue":"3","key":"1591_CR48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.amjsurg.2020.01.014","volume":"220","author":"TA James","year":"2020","unstructured":"James TA, Palis B, McCabe R, et al. Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery. Am J Surg. 2020;220(3):654\u20139.","journal-title":"Am J Surg"},{"issue":"7","key":"1591_CR49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2024.07.003","volume":"24","author":"MK Johnson","year":"2024","unstructured":"Johnson MK, Cortina CS, Aldakkak M, et al. The use of sentinel lymph node biopsy in patients undergoing mastectomy for DCIS. Clin Breast Cancer. 2024;24(7):611\u20139.","journal-title":"Clin Breast Cancer"},{"key":"1591_CR50","doi-asserted-by":"crossref","first-page":"e35881","DOI":"10.1371\/journal.pone.0035881","volume":"7","author":"W Zhou","year":"2012","unstructured":"Zhou W, He Z, Xue J, et al. Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes. PLoS ONE. 2012;7:e35881.","journal-title":"PLoS ONE"},{"key":"1591_CR51","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O","volume":"76","author":"R Lauria","year":"1995","unstructured":"Lauria R, Perrone F, Carlomagno C, et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer. 1995;76:1772\u20138.","journal-title":"Cancer"},{"key":"1591_CR52","doi-asserted-by":"crossref","first-page":"101756","DOI":"10.1016\/j.eclinm.2022.101756","volume":"55","author":"T Reimer","year":"2022","unstructured":"Reimer T, Stachs A, Veselinovic K, INSEMA Investigators, et al. Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer. EClinicalMedicine. 2022;55:101756.","journal-title":"EClinicalMedicine."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01591-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:45:26Z","timestamp":1764917126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01591-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5904084\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures followed were in accordance with the Helsinki Declaration and its later amendments. The data released by the SEER database were publicly available and does not require informed patient consent because cancer is a reportable disease in every state in the USA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"82"}}